Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression

REFERENCES

• Rosewicz, S.; Wiedenman, B. Pancreatic carcinoma. Lancet 1997, 349, 485–489.
   PubMed Web of Science ®Google Scholar
• Lowenfels, A.B.; Maisonneuve, P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006, 20, 197–209.
   PubMed Web of Science ®Google Scholar
• Michaud, D.S. Epidemiology of pancreatic cancer. Minerva Chir 2004, 59, 99–111.
   PubMedGoogle Scholar
• Mahboubi, K.; Li, F.; Plescia, J.; Kirkiles-Smith, N.C.; Mesri, M.; Du, Y.; Carroll, J.M.; Elias, J.A.; Altieri, D.C.; Pober, J.S. Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest 2001, 81, 327–334.
   PubMed Web of Science ®Google Scholar
• Hsieh, F.-C.; Cheng, G.; Lin, J. Evaluation of potential STAT3-regulated genes in human breast cancer. Biochem and Biophys Res Comm 2000, 335, 292–299.
   Google Scholar
• Satoh, K.; Kaneko, K.; Hirota, M.; Masamune, A.; Satoh, A.; Shimosegawa, T. Expression of survivin/BIRC5 is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 2001, 15, 271–278.
   Google Scholar
• Gritsko, T.; Williams, A.; Turkson, J.; Kaneko, S.; Bowman, T.; Huang, M.; Nam, S.; Eweis, I.; Diaz, N.; Sullivan, D.; Yoder, S.; Enkemann, S.; Eschrich, S.; Lee, J.H.; Beam, C.; Cheng, J.; Minton, S.; Muro-Cacho, C.A.; Jove, R. Persistent activation of Stat3 signalling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 2006, 12, 11–19.
   PubMed Web of Science ®Google Scholar
• Schust, J.; Sperl, B.; Holli, A.; Mayer, T.U.; Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006, 13, 1235–1242.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, A.; Banerjee, S.; Stafford, L.J.; Xia, C.; Liu, M.; Aggarwal, B.B. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002, 21, 8852–8861.
   PubMed Web of Science ®Google Scholar
• Han, S.S.; Chung, S.T.; Robertson, D.A.; Ranjan, D.; Bondada, S. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by down-regulation of egr-1, c-myc, bcl-xl, NF-kappaB, p53. Clin Immunol 1999, 93, 152–161.
   PubMed Web of Science ®Google Scholar
• Anto, R.J.; Mukhopadhyay, A.; Denning, K.; Aggarwal, B.B. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 2002, 23, 143–150.
   PubMed Web of Science ®Google Scholar
• Sahu, R.; Srivastava, S. The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J Natl Cancer Inst 2009, 101, 176–193.
   PubMed Web of Science ®Google Scholar
• Turkson, J.; Jove, R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 2000, 19, 6613–6623.
   PubMed Web of Science ®Google Scholar
• Niu, G.; Heller, R.; Catlett-Falcone, R. Gene therapy with dominant-negative STAT3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res 1999, 59, 5059–5063.
   PubMed Web of Science ®Google Scholar
• Ni, Z.; Lou, W.; Leman, E.S.; Gao, A.C. Inhibition of constitutively activated STAT3 signalling pathway suppresses growth of prostate cancer cells. Cancer Res 2000, 60, 1225–1228.
   PubMed Web of Science ®Google Scholar
• Leu, T.H.; Su, S.L.; Chuang, Y.C.; Maa, M.C. Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochem Pharmacol 2003, 17, 2323–2331.
   Google Scholar
• Tikhomirov, O.; Carpenter, G. Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation. Cancer Res 2003, 63, 39–44.
   PubMed Web of Science ®Google Scholar
• Korutla, L.; Kumar, R. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta 1994, 3, 597–600.
   Google Scholar
• Buettner, R.; Mora, L.B.; Jove, R. Activated STAT signalling in human tumors provides novel molecular targets for therapeutic intervention. Review. Clin Cancer Res 2002, 8, 945–954.
   PubMed Web of Science ®Google Scholar
• Yoshimura, A. Signal transduction of inflammation cytokines and tumor development. Cancer Sci 2006, 97, 439–447.
   PubMed Web of Science ®Google Scholar
• Scholz, A.; Heinze, S.; Detjen, K.M.; Peters, M.; Welzel, M.; Hauff, P.; Schirner, M.; Wiedenmann, B.; Rosewicz, S. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 2003, 125, 891–905.
   PubMed Web of Science ®Google Scholar
• Lian, J.P.; Word, B. Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein. Anticancer Res 2004, 24, 133–137.
   PubMed Web of Science ®Google Scholar
• Frank, D.A. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 2007, 251, 199–210.
   PubMed Web of Science ®Google Scholar
• Glienke, W.; Maute, L.; Wicht, J.; Bergmann, L. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells. Eur J Cancer 2009, 5, 874–880.
   Google Scholar
• Song, H.; Wang, R.; Wang, S.; Lin, J. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci USA 2005, 13, 4700–4705.
   Google Scholar
• Ferrajoli, A.; Faderl, S.; Van, Q.; Koch, P.; Harris, D.; Liu, Z.; Hazan-Halevy, I.; Wang, Y.; Kantarjian, H.M.; Priebe, W.; Estrov, Z. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res 2007, 23, 11291–11299.
   Google Scholar
• Kami, K.; Doi, R.; Koizumi, M.; Toyoda, E.; Mori, T.; Ito, D.; Kawaguchi, Y.; Fujimoto, K.; Wada, M.; Miyatake, S.-I.; Imamura, M. Down-regulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 2005, 138, 299–305.
   PubMed Web of Science ®Google Scholar